Neovascular age-related macular degeneration (AMD) is a significant cause of severe, irreversible vision loss in older adults. This condition is characterized by the growth of abnormal blood vessels under the retina, leading to rapid and severe vision loss. The market for neovascular AMD treatment was valued at USD 11 billion in 2023 across seven major […]